Background
Methods
Study setting
Study visits and participants
Detection of P. falciparum infections by qPCR
SNPs genotyping in fluidigm system
Haemoglobin genotyping
IL-1β and IL-1RA cytokine levels in cord blood
Definitions and genetic association analysis
Results
Characteristics of cases and controls groups
Variables | Malaria infection | Clinical malaria | ||||
---|---|---|---|---|---|---|
Cases (527) | Controls (129) | P-value | Cases (N = 411) | Controls (N = 245) | P-value | |
Maternal characteristics | ||||||
Age (years, mean ± SD) | 26.5 ± 6.3 | 26.2 ± 6.2 | 0.641 | 26.4 ± 6.2 | 26.4 ± 6.3 | 0.988 |
Gravidity (no. (%)) | 0.176 | 0.250 | ||||
Primigravida | 88 (16.7) | 25 (19.4) | 69 (16.8) | 44 (18.0) | ||
Secundigravida | 92 (17.5) | 14 (10.8) | 74 (18.0) | 32 (13.0) | ||
Multigravida | 347 (65.8) | 90 (69.8) | 268 (65.2) | 169 (69.0) | ||
MiP preventive strategy | ||||||
Standard IPTp-SP | 262 (49.7) | 70 (54.3) | 0.355 | 212 (51.6) | 120 (49.0) | 0.520 |
CSST/IPTp-SP | 265 (50.3) | 59 (45.7) | 199 (48.4) | 125 (51.0) | ||
SP doses uptake | ||||||
< 3 doses | 283 (53.7) | 52 (40.3) | 0.006 | 223 (54.3) | 112 (45.7) | 0.034 |
≥ 3 doses | 244 (46.3) | 77 (59.7) | 188 (45.7) | 133 (54.3) | ||
ITN usagea | 413 (78.4) | 108 (83.7) | 0.152 | 326 (79.3) | 195 (79.6) | 0.934 |
Infant’s characteristics | ||||||
Birth season [no. in malaria high-transmission season (%)] | 323 (61.3) | 84 (65.1) | 0.422 | 242 (58.9) | 165 (67.4) | 0.031 |
Gender [no. females (%)] | 272 (51.6) | 64 (49.6) | 0.684 | 201 (48.9) | 135 (55.1) | 0.125 |
LBW (< 2500 g) (no. (%)) | 45 (8.5) | 6 (4.6) | 0.140 | 40 (9.7) | 11 (4.5) | 0.015 |
PME (no. (%)) | < 0.001 | 0.021 | ||||
Active PM | 113 (23.7) | 16 (13.8) | 87 (23.1) | 42 (19.4) | ||
Past PM | 223 (46.8) | 43 (37.0) | 177 (47.1) | 89 (41.0) | ||
MPI | 53 (11.1) | 19 (16.4) | 47 (12.5) | 25 (11.5) | ||
Non-exposed | 88 (18.4) | 38 (32.8) | 65 (17.3) | 61 (28.1) | ||
Ethnicity [no. (%)] | 0.443 | 0.410 | ||||
Mossi | 471 (89.4) | 122 (94.6) | 366 (89.1) | 227 (92.7) | ||
Gourounsi | 52 (9.9) | 6 (4.6) | 42 (10.2) | 16 (6.5) | ||
Fulani | 3 (0.6) | 1 (0.8) | 2 (0.5) | 2 (0.8) | ||
Samo | 1 (0.2) | 0 (0.0) | 1 (0.2) | 0 (0.0) | ||
Haemoglobinb | ||||||
AA | 293 (56.8) | 75 (58.6) | 0.960 | 235 (58.3) | 133 (55.2) | 0.428 |
AC | 137 (26.5) | 34 (26.6) | 100 (24.8) | 71 (29.5) | ||
AS | 67 (13.0) | 16 (12.5) | 53 (13.2) | 30 (12.4) | ||
SC | 12 (2.3) | 2 (1.5) | 8 (2.0) | 6 (2.5) | ||
SS | 7 (1.4) | 1 (0.8) | 7 (1.7) | 1 (0.4) |
Association between immune genetic variants and malaria infection
Gene | SNPs | Genotyping success N (%) | Overall call ratea | Maj/MinA | MAF | HWE (P value) | Malaria infection | Clinical malaria | ||
---|---|---|---|---|---|---|---|---|---|---|
MAF Cases | MAF Controls | MAF Cases | MAF Controls | |||||||
TLR1 | rs4833095 | 645 (98.3) | 98.8 | C/T | 9.5 | 0.600 | 9.1 | 11.1 | 9.1 | 10.0 |
TLR4 | rs4986790 | 654 (99.7) | 98.4 | A/G | 9.0 | 0.999 | 9.2 | 8.1 | 9.1 | 8.8 |
TLR9 | rs5743836 | 653 (99.5) | 98.9 | A/G | 42.3 | 0.600 | 42.4 | 42.2 | 41.3 | 44.1 |
TLR9 | rs352139 | 654 (99.7) | 99.3 | C/T | 43.0 | 0.018 | 43.6 | 40.6 | 44.1 | 41.2 |
TLR9 | rs352140 | 645 (98.3) | 98.9 | C/T | 24.2 | < 0.001 | 24.5 | 23.1 | 25.3 | 22.3 |
IL-4 | rs2243250 | 655 (99.8) | 96.4 | T/C | 22.1 | 0.600 | 21.8 | 23.3 | 22.3 | 21.6 |
IL-10 | rs1800896 | 619 (94.4) | 98.6 | T/C | 31.1 | 0.024 | 31.4 | 29.9 | 31.5 | 30.4 |
IL-10 | rs1800890 | 650 (99.1) | 97.8 | A/T | 20.1 | 0.114 | 20.3 | 19.7 | 21.1 | 18.5 |
IL-17F | rs4715291 | 655 (99.8) | 99.0 | C/T | 15.6 | 0.415 | 16.2 | 13.6 | 16.2 | 14.7 |
IL-1β | rs1143634 | 654 (99.7) | 99.0 | G/A | 11.7 | 0.960 | 10.5 | 16.7 | 10.1 | 14.3 |
TNF | rs1800629 | 655 (99.8) | 98.8 | G/A | 14.5 | 0.961 | 14.1 | 16.0 | 14.4 | 14.7 |
TNF | rs3093664 | 656 (100) | 98.9 | A/G | 5.6 | 0.600 | 5.5 | 6.2 | 5.2 | 6.3 |
TNF | rs3093662 | 392 (59.7) | 97.4 | A/G | 5.7 | – | – | – | – | – |
IFNR1 | rs10213701 | 655 (99.8) | 98.6 | T/A | 36.4 | 0.863 | 36.5 | 36.0 | 37.3 | 34.8 |
IFNR1 | rs10065633 | 656 (100) | 99.0 | T/C | 50.8 | 0.601 | 51.3 | 48.4 | 51.0 | 50.4 |
NOS2A | rs2297518 | 656 (100) | 99.4 | G/A | 8.2 | 0.180 | 8.5 | 6.6 | 8.4 | 7.8 |
FcγRIIA/CD32 | rs1801274 | 648 (98.8) | 98.9 | G/A | 32.6 | 0.961 | 30.4 | 41.4 | 29.8 | 37.2 |
Gene | SNPs | Alleles or genotypes | Model | Univariate analysis | Multivariate analysisa | ||
---|---|---|---|---|---|---|---|
OR (95%CI) | P | AOR (95%CI) | P | ||||
Allele-based analysis | |||||||
TLR1 | rs4833095 | T vs C | – | 0.80 (0.51–1.24) | 0.318 | 0.89 (0.54–1.47) | 0.660 |
TLR4 | rs4986790 | G vs A | – | 1.15 (0.70–1.88) | 0.581 | 1.44 (0.82–2.53) | 0.204 |
TLR9 | rs5743836 | G vs A | – | 1.01 (0.76–1.32) | 0.972 | 0.98 (0.72–1.33) | 0.760 |
TLR9 | rs352139 | T vs C | – | 1.13 (0.85–1.49) | 0.384 | 1.22 (0.89–1.66) | 0.219 |
IL-4 | rs2243250 | C vs T | – | 0.91 (0.66–1.27) | 0.606 | 0.89 (0.63–1.27) | 0.534 |
IL-10 | rs1800896 | C vs T | – | 1.07 (0.78–1.46) | 0.664 | 1.07 (0.76–1.53) | 0.685 |
IL-10 | rs1800890 | T vs A | – | 1.04 (0.73–1.46) | 0.835 | 1.10 (0.75–1.61) | 0.614 |
IL-17F | rs4715291 | T vs C | – | 1.23 (0.83–1.82) | 0.305 | 1.11 (0.72–1.71) | 0.629 |
IL-1β | rs1143634 | A vs G | – | 0.58 (0.40–0.86) | 0.006 | 0.52 (0.34–0.80) | 0.003 |
TNF-α | rs1800629 | A vs G | – | 0.86 (0.59–1.26) | 0.444 | 0.91 (0.60–1.38) | 0.669 |
TNF-α | rs3093664 | G vs A | – | 0.88 (0.50–1.56) | 0.663 | 0.93 (0.48–1.78) | 0.826 |
IFNR1 | rs10213701 | A vs T | – | 1.02 (0.77–1.35) | 0.891 | 0.97 (0.71–1.34) | 0.888 |
IFNR1 | rs10065633 | C vs T | – | 1.12 (0.84–1.47) | 0.407 | 1.20 (0.88–1.63) | 0.238 |
NOS2A | rs2297518 | A vs G | – | 1.32 (0.77–2.26) | 0.306 | 1.28 (0.71–2.33) | 0.408 |
FcγRIIA/CD32 | rs1801274 | A vs G | – | 0.62 (0.47–0.82) | < 0.001 | 0.51 (0.37–0.70) | < 0.001 |
Genotype-based analysisb | |||||||
TLR1 | rs4833095 | TT vs TC/CC | Recessive | 0.60 (0.11–3.14) | 0.423 | 0.57 (0.10–3.18) | 0.521 |
TLR4 | rs4986790 | GA/GG vs AA | Dominant | 1.11 (0.66–1.86) | 0.828 | 1.43 (0.79–2.58) | 0.237 |
TLR9 | rs5743836 | GG vs GA/AA | Recessive | 0.87 (0.54–1.40) | 0.565 | 0.95 (0.56–1.62) | 0.861 |
TLR9 | rs352139 | TT vs TC/CC | Recessive | 1.30 (0.79–2.14) | 0.291 | 1.57 (0.89–2.77) | 0.117 |
IL-4 | rs2243250 | TC vs TT/CC | Over-dominant | 0.93 (0.62–1.40) | 0.730 | 0.91 (0.58–1.43) | 0.695 |
IL-10 | rs1800896 | CT vs TT/CC | Over-dominant | 1.32 (0.86–2.02) | 0.201 | 1.60 (0.99–2.61) | 0.057 |
IL-10 | rs1800890 | TA vs TT/AA | Over-dominant | 1.33 (0.86–2.07) | 0.203 | 1.52 (0.93–2.48) | 0.098 |
IL-17F | rs4715291 | TT vs TC/CC | Recessive | 1.15 (0.73–1.83) | 0.537 | 1.28 (0.35–4.61) | 0.710 |
IL-1β | rs1143634 | AG/AA vs GG | Dominant | 0.58 (0.37–0.89) | 0.013 | 0.52 (0.32–0.84) | 0.007 |
TNF-α | rs1800629 | AA vs GA/GG | Recessive | 1.34 (0.29–6.13) | 0.704 | 1.41 (0.28–7.10) | 0.677 |
TNF-α | rs3093664 | GA vs GG/AA | Over-dominant | 0.74 (0.41–1.35) | 0.325 | 0.77 (0.39–1.52) | 0.454 |
IFNR1 | rs10065633 | TC vs CC/TT | Over-dominant | 0.89 (0.61–1.32) | 0.574 | 0.90 (0.58–1.37) | 0.619 |
IFNR1 | rs10213701 | TA vs AA/TT | Over-dominant | 0.85 (0.58–1.25) | 0.415 | 0.86 (0.56–1.32) | 0.492 |
NOS2A | rs2297518 | GA/AA vs GG | Over-dominant | 1.32 (0.74–2.34) | 0.342 | 1.30 (0.69–2.46) | 0.421 |
FcγRIIA/CD32 | rs1801274 | GA/AA vs GG | Dominant | 0.52 (0.34–0.78) | 0.001 | 0.45 (0.28–0.70) | < 0.001 |
Association between immune genetic variants and clinical malaria
Gene | SNPs | Alleles/genotypes | Model | Univariate analysis | Multivariate analysisa | ||
---|---|---|---|---|---|---|---|
OR (95%CI) | P | OR (95%CI) | P | ||||
Allele-based analysis | |||||||
TLR1 | rs4833095 | T vs C | – | 0.90 (0.62–1.33) | 0.608 | 0.96 (0.63–1.46) | 0.844 |
TLR4 | rs4986790 | G vs A | – | 1.04 (0.70–1.54) | 0.838 | 1.19 (0.76–1.87) | 0.442 |
TLR9 | rs5743836 | G vs A | – | 0.89 (0.71–1.12) | 0.324 | 0.82 (0.64–1.06) | 0.137 |
TLR9 | rs352139 | T vs C | – | 1.13 (0.90–1.42) | 0.296 | 1.09 (0.84–1.40) | 0.524 |
IL-4 | rs2243250 | C vs T | – | 1.04 (0.79–1.36) | 0.772 | 0.97 (0.72–1.31) | 0.857 |
IL-10 | rs1800896 | C vs T | – | 1.05 (0.82–1.35) | 0.676 | 1.00 (0.76–1.33) | 0.982 |
IL-10 | rs1800890 | T vs A | – | 1.17 (0.88–1.56) | 0.268 | 1.14 (0.83–1.56) | 0.423 |
IL-17F | rs4715291 | T vs C | – | 1.12 (0.82–1.53) | 0.462 | 0.98 (0.70–9.07) | 0.918 |
IL-1β | rs1143634 | A vs G | – | 0.68 (0.48–0.95) | 0.025 | 0.66 (0.46–0.97) | 0.032 |
TNF-α | rs1800629 | A vs G | – | 0.97 (0.70–1.33) | 0.843 | 1.08 (0.76–1.53) | 0.682 |
TNF-α | rs3093664 | G vs A | – | 0.82 (0.51–1.32) | 0.406 | 0.73 (0.43–1.25) | 0.259 |
IFNR1 | rs10213701 | A vs T | – | 1.11 (0.88–1.41) | 0.361 | 1.15 (0.89–1.50) | 0.283 |
IFNR1 | rs10065633 | C vs T | – | 1.02 (0.82–0.82) | 0.843 | 1.06 (0.82–1.36) | 0.644 |
NOS2A | rs2297518 | A vs G | – | 1.09 (0.72–1.65) | 0.682 | 1.32 (0.83–2.10) | 0.239 |
FcγRIIA/CD32 | rs1801274 | A vs G | – | 0.71 (0.56–0.90) | 0.005 | 0.68 (0.52–0.89) | 0.005 |
Genotype-based analysisb | |||||||
TLR1 | rs4833095 | TT vs TC/CC | Recessive | 0.44 (0.10–1.99) | 0.286 | 0.50 (0.11–2.36) | 0.388 |
TLR4 | rs4986790 | GA/GG vs AA | Dominant | 1.02 (0.67–1.56) | 0.910 | 1.28 (0.79–2.06) | 0.313 |
TLR9 | rs5743836 | GG vs GA/AA | Recessive | 0.81 (0.54–1.20) | 0.295 | 0.77 (0.50–1.20) | 0.250 |
TLR9 | rs352139 | TT vs TC/CC | Recessive | 1.33 (0.90–1.98) | 0.155 | 1.33 (0.86–2.06) | 0.197 |
IL-4 | rs2243250 | TC vs TT/CC | Over-dominant | 0.96 (0.68–1.35) | 0.818 | 0.83 (0.57–1.20) | 0.326 |
IL-10 | rs1800896 | CT vs TT/CC | Over-dominant | 1.07 (0.76–1.50) | 0.690 | 1.29 (0.88–1.88) | 0.185 |
IL-10 | rs1800890 | TA vs TT/AA | Over-dominant | 1.41 (0.99–2.01) | 0.059 | 1.48 (0.99–2.19) | 0.052 |
IL-17F | rs4715291 | TT vs TC/CC | Recessive | 1.29 (0.52–3.02) | 0.583 | 0.92 (0.35–2.46) | 0.882 |
IL-1β | rs1143634 | AA vs AG/GG | Recessive | 0.29 (0.07–1.18) | 0.086 | 0.14 (0.03–0.78) | 0.024 |
TNF-α | rs1800629 | AA vs GA/GG | Recessive | 1.34 (0.41–4.41) | 0.626 | 2.15 (0.54–8.59) | 0.279 |
TNF-α | rs3093664 | GA vs GG/AA | Over-dominant | 0.85 (0.50–1.42) | 0.529 | 0.70 (0.40–1.25) | 0.230 |
IFNR1 | rs10065633 | TC vs CC/TT | Over-dominant | 1.03 (0.75–1.41) | 0.869 | 1.14 (0.80–1.61) | 0.476 |
IFNR1 | rs10213701 | TA/AA vs TT | Dominant | 1.13 (0.82–1.55) | 0.468 | 1.20 (0.84–1.70) | 0.331 |
NOS2A | rs2297518 | GA/AA vs GG | Dominant | 1.11 (0.71–1.73) | 0.656 | 1.30 (0.79–2.14) | 0.307 |
FcγRIIA/CD32 | rs1801274 | GA/AA vs GG | Dominant | 0.65 (0.47–0.89) | 0.008 | 0.58 (0.41–0.84) | 0.003 |